NIKOLAS RAMOS: Open Payments
NPI 1205678331 · TEMPE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$547 in 12 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $308 · 2025 $547
Food & beverage: $547
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 7 | $154 |
| Alpha Cognition USA, Inc. | 3 | $138 |
| Neurocrine BioSciences, Inc. | 1 | $136 |
| E.R. Squibb & Sons, L.L.C. | 1 | $119 |
Products named: NUPLAZID, Zunveyl, INGREZZA, COBENFY.
Industry payments across AZ — which companies pay providers there.
